Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy

被引:6
作者
Pili-Floury, Sebastien [1 ,2 ,3 ]
Royer, Bernard [4 ,5 ]
Bartholin, Frederique [1 ]
Crumiere, Nathalie [1 ]
Combe, Marielle [1 ]
Chalopin, Jean-Marc [2 ,5 ,6 ]
Pivot, Xavier [2 ,5 ,7 ]
Heyd, Bruno [2 ,5 ,8 ]
Chauffert, Bruno [9 ]
Samain, Emmanuel [1 ,2 ,3 ]
机构
[1] CHU Besancon, Dept Anesthesiol & Intens Care Med, F-25000 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] INSERM IFR 133, EA 3920, F-25000 Besancon, France
[4] CHU Besancon, Dept Pharmacol, F-25000 Besancon, France
[5] INSERM UMR 645, F-25000 Besancon, France
[6] CHU Besancon, Dept Nephrol, F-25000 Besancon, France
[7] CHU Besancon, Dept Oncol, F-25000 Besancon, France
[8] CHU Besancon, Dept Gen Surg, F-25000 Besancon, France
[9] Georges Francois Leclerc Ctr, Dept Oncol, F-21000 Dijon, France
关键词
Ovarian cancer; Intraperitoneal chemotherapy; Cisplatin; Epinephrine; Renal function; CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN-CANCER; NEPHROTOXICITY; FAILURE; FEASIBILITY; CARBOPLATIN; MORTALITY; CARCINOMA;
D O I
10.1016/j.ejogrb.2011.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure. Study design: This prospective observational study was carried out on 77 consecutive patients who underwent cisplatin-based IPC procedures, with (n = 23) or without (n = 54) intra-peritoneal epinephrine, for advanced ovarian cancer. Postoperative renal function was assessed using serial serum creatinine measurements and was based on serum creatinine changes from pre-operative values, according to the risk, injury, failure, loss, end-stage kidney disease (RIFLE) classification. Patients were divided into two groups according to postoperative renal function: patients with renal injury or failure (IF group) or patients with no renal alteration or renal risk (NR group). Clinical variables were compared between the IF and NR groups using univariate and multivariate analysis. Results: Postoperative acute change in renal function was observed in 34 (44.2%) patients (unimodal distribution), among whom 23 patients (29.8%) constituted the IF group. In univariate analysis, the absence of epinephrine in the IPC bath, a higher duration of severe hypotension, a lower postoperative blood protein level, and a lower volume of intra-operative diuresis were significantly associated with the occurrence of renal injury or failure. In multivariate analysis, the absence of epinephrine was the only factor associated with the occurrence of moderate to severe acute renal failure (odds ratio [95% confidence interval] = 4.49 [1.36-14.80]). Conclusions: Transient acute renal dysfunction after cisplatin-based IPC associated with cytoreductive surgery is frequent and intra-peritoneal epinephrine plays a protective role. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 47 条
  • [31] Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)
    Liu, Lili
    Zhang, Ning
    Min, Jie
    Su, Haichuan
    Wang, Hongmei
    Chen, Dongxu
    Sun, Li
    Zhang, Hongwei
    Li, Wei
    Zhang, Helong
    ONCOTARGET, 2016, 7 (16) : 21570 - 21578
  • [32] Multicystic peritoneal mesothelioma treated with complete cytoreductive surgery, peritonectomy and hyperthermic intra-peritoneal chemotherapy-A case report
    Padmanabhan, Naveen
    Ishibashi, Haruaki
    Nishihara, Kazurou
    Sako, Shouzou
    Katayama, Kanji
    Wakama, Satoshi
    Kamada, Yasuyuki
    Yonemura, Yutaka
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 74 : 152 - 157
  • [33] Cyto-reductive Surgery combined with Hyperthermic Intra-Peritoneal Chemotherapy for Peritoneal Surface Malignancies: Current treatment and results
    Sommariva, Antonio
    Pilati, Pierluigi
    Rossi, Carlo Riccardo
    CANCER TREATMENT REVIEWS, 2012, 38 (04) : 258 - 268
  • [34] Complete pathological response of high grade appendicular neoplasm induced Pseudomyxoma Peritonei (PMP) after neoadjuvant intra-peritoneal chemotherapy: A case report
    Padmanabhan, Naveen
    Ishibashi, Haruaki
    Nishihara, Kazurou
    Sako, Shouzou
    Katayama, Kanji
    Wakama, Satoshi
    Kamada, Yasuyuki
    Yonemura, Yutaka
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 72 : 117 - 121
  • [35] Increased Incidence of Central Venous Catheter-Related Infection in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy
    Waters, Peadar S.
    Smith, Andrew W.
    Fitzgerald, Emer
    Khan, Faraz
    Moran, Brendan J.
    Shields, Conor J.
    Lynch, Breda L.
    O'Loughlin, Colman
    Lynch, Maureen
    Mulsow, Jurgen
    SURGICAL INFECTIONS, 2019, 20 (06) : 465 - 471
  • [36] Effect of platelet-rich plasma on colon anastomosis in rats in which hyperthermic intra-peritoneal chemotherapy was performed using 5-fluorouracil
    Goksu, Mustafa
    Alaku, Huseyin
    Ertan, Sirac
    Akgun, Sadik
    ANZ JOURNAL OF SURGERY, 2020, 90 (11) : 2290 - 2297
  • [37] Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial
    Topal, Baki
    Demey, Karel
    Topal, Halit
    Jaekers, Joris
    Van Cutsem, Eric
    Vandecaveye, Vincent
    Sagaert, Xavier
    Prenen, Hans
    BMC CANCER, 2017, 17
  • [38] Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
    Elias, D
    Bonnay, A
    Puizillou, JM
    Antoun, S
    Demirdjian, S
    El Otmany, A
    Pignon, JP
    Drouard-Troalen, L
    Ouellet, JF
    Ducreux, M
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 267 - 272
  • [39] Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy
    Singh, Bhavneet
    Singh, Gurkirat
    Pourgholami, Mohammad
    Alzahrani, Nayef
    Morris, David L.
    ANTICANCER RESEARCH, 2018, 38 (10) : 5917 - 5921
  • [40] Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial
    Baki Topal
    Karel Demey
    Halit Topal
    Joris Jaekers
    Eric Van Cutsem
    Vincent Vandecaveye
    Xavier Sagaert
    Hans Prenen
    BMC Cancer, 17